The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Infections and anti–tumor necrosis factor α therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
Present, D. H., Rutgeerts, P., Targan, S., Hanauer, S. B., Mayer, L., van Hogezand, R. A., Podolsky, D. K., Sands, B. E., Braakman, T., DeWoody, K. L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905063401804 · Cited by 2,752
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448
Beutler, B., Milsark, I. W., & Cerami, A. C. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,352
Maini, R., St Clair, E. W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05246-0 · Cited by 2,345
Weinblatt, M. E., Keystone, E. C., Furst, D. E., Moreland, L. W., Weisman, M. H., Birbara, C. A., Teoh, L. A., Fischkoff, S. A., & Chartash, E. K. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10697 · Cited by 1,757
Self-citationA Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
Bathon, J. M., Martin, R. W., Fleischmann, R. M., Tesser, J. R., Schiff, M. H., Keystone, E. C., Genovese, M. C., Wasko, M. C., Moreland, L. W., Weaver, A. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432201 · Cited by 1,730
Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,622
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
Mease, P. J., Goffe, B. S., Metz, J., VanderStoep, A., Finck, B., & Burge, D. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02530-7 · Cited by 1,446
Kindler, V., Sappino, A.-P., Grau, G. E., Piguet, P.-F., & Vassalli, P. (1989) · Cell · doi:10.1016/0092-8674(89)90676-4 · Cited by 1,254
Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis
Lovell, D. J., Giannini, E. H., Reiff, A., Cawkwell, G. D., Silverman, E. D., Nocton, J. J., Stein, L. D., Gedalia, A., Ilowite, N. T., Wallace, C. A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003163421103 · Cited by 1,246
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H., & Benjamin, E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342603 · Cited by 1,241
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
(2016) · Pediatric Clinical Practice Guidelines & Policies · doi:10.1542/9781610020190-part06-targeted · Cited by 920
Abraham, E. (1998) · The Lancet · doi:10.1016/s0140-6736(00)80009-4 · Cited by 624
Abraham, E. H., Anzueto, A., Gutiérrez, G., Tessler, S., Pedro, G. S. S., Wunderink, R. G., Nogare, A. R. D., Nasraway, S. A., Berman, S., Cooney, R. N., et al. (1998) · PubMed · Cited by 622
Jasmer, R. M., Nahid, P., & Hopewell, P. C. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp021045 · Cited by 497
Extrapulmonary Tuberculosis in the United States
Rieder, H. L., Snider, D. E., & Cauthen, G. M. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.2.347 · Cited by 466
Lee, J., Slifman, N. R., Gershon, S. K., Edwards, E. T., Schwieterman, W. D., Siegel, J. N., Wise, R. P., Brown, S. L., Udall, J. N., & Braun, M. M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10583 · Cited by 443
Evidence that tumor necrosis factor has an important role in antibacterial resistance.
Havell, E. A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.9.2894 · Cited by 405
Slifman, N. R., Gershon, S. K., Lee, J., Edwards, E. T., & Braun, M. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10758 · Cited by 383
Martínez Martínez, L. (1990) · PubMed · Cited by 335
Invasive Pulmonary Aspergillosis Associated with Infliximab Therapy
(2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441415 · Cited by 330
Spriggs, D. R., Sherman, M. L., Michie, H., Arthur, K. A., Imamura, K., Wilmore, D., Frei, E., & Kufe, D. W. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.13.1039 · Cited by 308
Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis.
Mehrad, B., Strieter, R. M., & Standiford, T. J. (1999) · PubMed · Cited by 264
Role of TNF-α in Pulmonary Host Defense in Murine Invasive Aspergillosis
Mehrad, B., Strieter, R. M., & Standiford, T. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1633 · Cited by 240
van der Poll, T., Keogh, C. V., Buurman, W. A., & Lowry, S. F. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.2.9032201 · Cited by 200
Silva, A. T., Bayston, K. F., & Cohen, J. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.2.421 · Cited by 197
Allendoerfer, R., & Deepe, G. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.6072 · Cited by 180
Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice
Takashima, K., Tateda, K., Matsumoto, T., Iizawa, Y., Nakao, M., & Yamaguchi, K. (1997) · Infection and Immunity · doi:10.1128/iai.65.1.257-260.1997 · Cited by 179
Interferon- and Tumor Necrosis Factor- Protect Mice from Invasive Aspergillosis
Nagai, H., Guo, J., Choi, H., & Kurup, V. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.6.1554 · Cited by 174
Fatal Sepsis in a Patient With Rheumatoid Arthritis Treated With Etanercept
Baghai, M., Osmon, D. R., Wolk, D. M., Wold, L. E., Haidukewych, G. J., & Matteson, E. L. (2001) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)62418-x · Cited by 166
Gordin, F. M., Matts, J. P., Miller, C., Brown, L. S., Hafner, R., John, S. L., Klein, M., Vaughn, A., Besch, C. L., Perez, G., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370505 · Cited by 166
Allendoerfer, R., & Deepe, G. S. (1998) · PubMed · Cited by 164
Tuberculosis and Treatment with Infliximab
Myers, A., Clark, J., & Foster, H. (2002) · New England Journal of Medicine · doi:10.1056/nejm200202213460815 · Cited by 155
Roilides, E., Dimitriadou‐Georgiadou, A., Sein, T., Kadiltsoglou, I., & Walsh, T. J. (1998) · Infection and Immunity · doi:10.1128/iai.66.12.5999-6003.1998 · Cited by 153
Khan, K. Z., Muennig, P. A., Behta, M., & Zivin, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa021099 · Cited by 150
Herring, A. C., Lee, J., McDonald, R. A., Toews, G. B., & Huffnagle, G. B. (2002) · Infection and Immunity · doi:10.1128/iai.70.6.2959-2964.2002 · Cited by 140
Ehlers, S., Benini, J., Kutsch, S., Endres, R., Rietschel, E. T., & Pfeffer, K. (1999) · Infection and Immunity · doi:10.1128/iai.67.7.3571-3579.1999 · Cited by 131
Wellmer, A., Gerber, J., Ragheb, J., Zysk, G., Kunst, T., Av, S., Brück, W., & Nau, R. (2001) · Infection and Immunity · doi:10.1128/iai.69.11.6881-6886.2001 · Cited by 95
Rubin, R. H., Ikonen, T. S., Gummert, J. F., & Morris, R. E. (1999) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.1999.10104.x · Cited by 61
Self-citation
Cited by
Breedveld, F. C., Weisman, M. H., Kavanaugh, A. F., Cohen, S. B., Pavelka, K., Vollenhoven, R. V., Sharp, J., Perez, J. L., & Spencer‐Green, G. T. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21519 · Cited by 1,785
Allicin: Chemistry and biological properties
Borlinghaus, J., Albrecht, F., Gruhlke, M., Nwachukwu, I., & Slusarenko, A. (2014) · Molecules · doi:10.3390/molecules190812591 · Cited by 893
Pathirana, D., Ormerod, A., Saiag, P., Smith, C., Spuls, P., Nast, A., Barker, J., Bos, J., Burmester, G., Chimenti, S., et al. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03389.x · Cited by 703
Tubach, F., Salmon, D., Ravaud, P., Allanore, Y., Goupille, P., Bréban, M., Pallot‐Prades, B., Pouplin, S., Sacchi, A., Chichemanian, R. M., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24632 · Cited by 632
Therapeutic Strategies for Rheumatoid Arthritis
O'Dell, J. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040226 · Cited by 588
Metadata
- Authors
- Ellerin, T., Rubin, R. H., & Weinblatt, M. E.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2003-11
- Volume
- 48
- Issue
- 11
- Pages
- 3013-3022
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1990590525
- Cited by
- 284
- References
- 42
- FWCI
- 18.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.